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Th17BACKGROUND & AIMS: It is not clear how regulation of T-cell
function is altered during development of inﬂammatory bowel
diseases (IBD). We studied the mechanisms by which
geranylgeranyltransferase-mediated prenylation controls T-cell
localization to the intestine and chronic inﬂammation.
METHODS: We generated mice with T-cell–speciﬁc disruption
of the geranylgeranyltransferase type I, beta subunit gene
(Pggt1b), called Pggt1bDCD4 mice, or the ras homolog family
member A gene (Rhoa), called RhoaDCD4 mice. We also studied
mice with knockout of CDC42 or RAC1 and wild-type mice
(controls). Intestinal tissues were analyzed by histology,
multiphoton and confocal microscopy, and real-time polymer-
ase chain reaction. Activation of CDC42, RAC1, and RHOA were
measured with G-LISA, cell fractionation, and immunoblots. T
cells and lamina propria mononuclear cells from mice were
analyzed by ﬂow cytometry or transferred to Rag1–/– mice.
Mice were given injections of antibodies against integrin
alpha4beta7 or gavaged with the RORC antagonist GSK805. We
obtained peripheral blood and intestinal tissue samples from
patients with and without IBD and analyzed them by ﬂow
cytometry. RESULTS: Pggt1bDCD4 mice developed spontaneous
colitis, characterized by thickening of the intestinal wall, edema,ﬁbrosis, accumulation of T cells in the colon, and increased
expression of inﬂammatory cytokines. Compared with control
CD4þ T cells, PGGT1B-deﬁcient CD4þ T cells expressed
signiﬁcantly higher levels of integrin alpha4beta7, which reg-
ulates their localization to the intestine. Inﬂammation induced
by transfer of PGGT1B-deﬁcient CD4þ T cells to Rag1–/– mice
was blocked by injection of an antibody against integrin
alpha4beta7. Lamina propria of Pggt1bDCD4 mice had increased
numbers of CD4þ T cells that expressed RORC and higher
levels of cytokines produced by T-helper 17 cells (granulocyte-
macrophage colony-stimulating factor, interleukin [IL]17A,
IL17F, IL22, and tumor necrosis factor [TNF]). The RORC in-
verse agonist GSK805, but not antibodies against IL17A or
IL17F, prevented colitis in Pggt1bDCD4 mice. PGGT1B-deﬁcient
CD4þ T cells had decreased activation of RHOA. RhoADCD4
mice had a similar phenotype to Pggt1bDCD4 mice, including
development of colitis, increased numbers of CD4þ T cells in
colon, increased expression of integrin alpha4beta7 by CD4þ T
cells, and increased levels of IL17A and other inﬂammatory
cytokines in lamina propria. T cells isolated from intestinal
tissues from patients with IBD had signiﬁcantly lower levels
of PGGT1B than tissues from individuals without IBD.
WHAT YOU NEED TO KNOW
BACKGROUND AND CONTEXT
Although T cells have been identiﬁed as crucial regulators
of chronic intestinal inﬂammation in inﬂammatory bowel
diseases, the molecular factors driving altered T cell
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RHOA function, increasing CD4þ T-cell expression of integrin
alpha4beta7 and localization to colon, resulting in increased
expression of inﬂammatory cytokines and colitis. T cells iso-
lated from gut tissues from patients with IBD have lower levels
of PGGT1B than tissues from patients without IBD.responses in IBD are incompletely understood.
NEW FINDINGS
GGTaseI-mediated prenylation was identiﬁed as a new
regulator of T cell trafﬁcking and effector function. The
small GTPase RhoA was able to link defects in
GGTaseI-mediated prenylation with an augmented
a4b7-dependent colon tropism and pro-inﬂammatory
effector function of T lymphocytes.Keywords: Mouse Models; Prenylation; IBD; Immune
Regulation.
issue homeostasis in the gut is guaranteed by aLIMITATIONS
Further studies are needed in order to describe the
molecular mechanism behind local activation of
GGTaseI-deﬁcient T cells within the gut mucosa.
IMPACT
Of particular relevance in the context of colitis gut
homeostasis and IBD pathogenesis, Pggt1bDCD4 mice
spontaneously developed a chronic colitis and lamina
propria T cells of IBD patients could be characterized by
decreased GGTaseI expression.
§ Authors share co-senior authorship.
Abbreviations used in this paper: GGTI, geranylgeranyltransferase inhibi-
tor; GTP, guanosine-triphosphate; IBD, inﬂammatory bowel disease; IL,
interleukin; LPMCs, lamina propria mononuclear cells; SP, single positive.
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https://doi.org/10.1053/j.gastro.2019.07.007Tcomplex interaction between the different cellular
compartments of the intestinal mucosa.1 As a ﬁrst immu-
nological barrier, the epithelium segregates the luminal
content from the plethora of immune cells in the sub-
epithelial space.2 However, altered local immune responses
within the lamina propria trigger an overwhelming activa-
tion of inﬂammatory immune cells, which might promote
chronic inﬂammatory disorders, like in inﬂammatory bowel
disease (IBD).1 In particular, the function of gut-inﬁltrating
T cells has been identiﬁed as a key player in IBD patho-
genesis. Accordingly, interfering with exacerbated effector
T-cell responses could successfully be established as ther-
apeutic approaches in the clinical management of patients
with IBD.3
Prenylation is deﬁned as the posttranslational attach-
ment of isoprenoids to target proteins, relevantly affecting
protein function.4 The recent identiﬁcation of prenylation as
a novel intrinsic regulator of epithelial integrity5 implicates
that therapy strategies that are able to improve the pre-
nylation status of proteins in intestinal epithelial cells or to
trigger the function of speciﬁc downstream target proteins
may allow epithelial restoration in IBD.6 Therefore, an
improved understanding of prenylation-dependent
signaling cascades in nonepithelial cells, such as the T
cells, and their impact on the chronic inﬂammatory process
needs to be achieved.
Recent mouse studies demonstrated that lymphocyte-
speciﬁc genetic deletion of prenylation upstream regula-
tors (HMGCoR)7 or downstream targets (CDC42, RAC1,
RHOA)8–10 inﬂuence T-cell function. However, it remained
unclear whether the fate of T cells in the context of chronic
inﬂammation might depend on prenylation. We now
analyzed mice lacking the prenylation-catalyzing enzyme
PGGT1B11 within T cells, and could demonstrate that pre-
nylation controls localization and effector function of lym-
phocytes. The development of a spontaneous colitis in mice
carrying PGGT1B-deﬁcient T cells indicates that gut mucosal
homeostasis depends on prenylation in T cells. Among
prenylated proteins, we could demonstrate that RHOA plays
a crucial role in localization to the intestine and inﬂamma-
tory capacity of T cells. Together with our previous study,
this strongly supports the idea that patients with IBD might
beneﬁt from a therapeutic induction of prenylation or
improved RHOA function within the gut mucosa, which
could potentially carry a double beneﬁcial effect by acting
on adaptive and innate immune cells.Materials and Methods
Animals
Pggt1bﬂx,12 Cdc42ﬂx,13 Rac1ﬂx,14 and Rhoaﬂx15 mice were
crossbred with CD4Cre mice,16 to generate T-cell–speciﬁc
deletion of Pggt1b, Cdc42, Rac1, or Rhoa. Pggt1bDCD4 mice were
crossbred with ROSA26-tdTomato mice17 to generate reporter
mice. Animal studies were conducted in a gender- and age-
matched manner using littermates as control.
Human Samples
Human blood and tissue samples were obtained from
Department of Medicine 1, University Hospital Erlangen
(Germany).
Mouse Endoscopy
Mouse gut status was scored by high-resolution video
endoscopy as described recently.18
Thymocyte Transfer
Isolated thymocytes (mice  10 weeks of age) were stained
with carboxyﬂuorescein succinimidyl ester and injected
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later, tissues were collected and analyzed. In the repetitive
adoptive thymocyte transfer, thymocytes were injected twice
per day on 3 consecutive days; tissues were collected the day
after the last injection.
Lamina Propria Mononuclear Cell (LPMC)
transfer
Freshly isolated LPMCs (mice  10 weeks of age) were
injected intraperitoneally into Rag1–/– mice (0.5  106 cells/
mouse). Tissues were analyzed 4 weeks after cell transfer.
Anti-a4b7 Treatment
Mice were treated with 200 mg of LPAM-1 (BE0034; Bio-
XCell, West Lebanon, NH) or corresponding isotype control
antibodies via intraperitoneal injection 3 times per week from 4
until 15 weeks of age. In the LPMC transfer model, treatment
with LPAM-1 started on the day of adoptive cell transfer.
GSK805 Treatment
Mice were treated with the RORC inverse agonist GSK805
(10 mg/kg; Merck-Millipore, Burlington, MA) or corresponding
vehicle control via oral gavage 3 times per week from 4 until 15
weeks of age. GSK805 was dissolved in dimethyl sulfoxide and
then suspended in corn oil.
Intravital Microscopy
The intestine of anaesthetized mice was prepared for
intravital microscopy, as described recently.19 Time sequential
Z-stacks images were taken with a confocal microscope (SP8;
Leica, Wetzlar, Germany).
Cell Culture
Cells incubated in RPMI-1640 with GlutaMAX medium con-
taining FBS (10%) and 100 U mL1 penicillin, were stimulated
with anti-CD3 and anti-CD28 (1 mg/mL) or PMA (50 ng mL1)
and ionomycin (750 ngmL1) with or without brefeldin A (10 mg
mL1). Geranylgeranyltransferase inhibitor (GGTI)-298 (3mM)or
simvastatin (5 mM) were added 1 hour before stimulation; RHO
(CN03) or RAC1/CDC42 (CN02) activators (Cytoskeleton, Inc,
Denver, CO) were added 10 minutes before GGTI-298 treatment.
Flow Cytometry
Cells were stained in the presence of anti-mouse CD16/32
(Biolegend, San Diego, CA) or FcR block (Miltenyi, Bergisch
Gladbach, Germany), with speciﬁc antibodies (Supplementary
Table 1). The Foxp3 Transcription Factor Staining Buffer Set
(eBioscience, San Diego, CA) was used for intracellular staining.
Cells were acquired using a BD LSRFortessa (Beckton Dick-
inson, Franklin Lakes, NJ) or MQ10 (Miltenyi Biotec, Bergisch
Gladbach, Germany).
Histology
Hematoxylin-eosin–stained tissue samples were scored in a
blinded fashion, taking into account “inﬂammatory cell inﬁl-
trate” (0–4), “epithelial changes” (0–5), and “mucosal archi-
tecture” (0–5); resulting in a total score from 0 to 14.Immunoﬂuorescence Staining
Tissue cryosections were stained with speciﬁc antibodies
(Supplementary Table 2) and biotinylated-Streptavidin anti-
body pairs. Pictures were taken with upright or inverted
confocal microscopes (Leica). Image quantiﬁcation; cells per
ﬁeld; 3 ﬁelds per sample; 20 magniﬁcation.Label-free Multiphoton Microscopy
Multiphoton microscopy with spectral separation was
performed with an upright system (TriM-Scope II; LaVision
BioTec GmbH, Bielefeld, Germany) equipped with a femto-
second Ti-Sa-laser and a HC Fluotar L25x/0.95 W Visir
objective (Leica). The emission spectrum was separated by
dichroic mirrors and ﬁlters to detect the speciﬁc tissue
signals in 3 photomultiplier tubes. Second harmonics gen-
eration signals of collagen were collected at ranges 395 to
415 nm (blue) and autoﬂuorescence of NADH at 415 to 485
nm (green). tdTomato emission and autoﬂuorescence of
ﬂavins were detected at 540 to 580 nm (red). The ﬁeld of
view was 400 mm  400 mm. The excitation wavelength was
800 nm.Gene Expression Analysis
Total RNA was isolated (NucleoSpin RNA; Macherey-
Nagel, Duren, Germany) and retro-transcribed into comple-
mentary DNA (Bio-Rad, Hercules, CA). Gene expression was
measured by real-time polymerase chain reaction (Bio-Rad)
with SyberGreen and Quantitect primers (Qiagen, Hilden,
Germany). Gene expression was normalized to HPRT
expression.Immunoblotting
Protein extracts were obtained by incubation in mammalian
protein extraction reagent (Thermo Scientiﬁc, Waltham, MA).
For membrane fraction separation, lysis buffer without de-
tergents, and high-speed centrifugation steps were used.
Denaturized proteins were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and blotted onto
nitrocellulose membranes. Speciﬁc (Supplementary Table 3)
and horseradish peroxidase–linked antibodies were used for
chemoluminescence detection. Protein expression was
compared with the level of beta-actin.Small Guanosine-Triphosphate (GTP)ases
Activation Assay
CDC42, RAC1, and RHOA activation status was measured
with G-LISA Activation Assay (Cytoskeleton).Statistics
Data are expressed as mean ± SEM. Signiﬁcance analysis
was performed using 1-tailed Student t test, except where
indicated. For multiple comparisons, data were analyzed by 1-
way analysis of variance and least signiﬁcance difference post
hoc test. *P  .05; **P  .001; ***P  .0001 versus corre-
sponding control.
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PGGT1B-deﬁcient T Cells as Potent Inducers of
Chronic Colitis
To analyze the role of prenylation in adaptive immune
responses, we generated T-cell–speciﬁc conditional
knockout mice of geranylgeranyltransferase type I, beta
subunit gene (Pggt1bDCD4 mice). Cre-mediated Pggt1b
deletion in Pggt1bDCD4 mice affects speciﬁcally the T-cell
compartment (Supplementary Figure 1A), leading to
downregulated targeted gene expression in thymocytes
(Supplementary Figure 1B). Consistently, we could show
decreased PGGT1B protein expression and inhibition of
prenylation in thymus (Supplementary Figure 1C). Thus, we
conﬁrmed that Pggt1bDCD4 mice carry a T-cell–speciﬁc
deﬁciency of PGGT1B.
Although they did not demonstrate any modiﬁcation of
their general status up to 10 weeks of age, Pggt1bDCD4 mice
develop a rectal prolapse (Figure 1A), which was associated
with spontaneous development of colitis starting at 10
weeks of age and being evident in all 15-week-old
Pggt1bDCD4 mice. High-resolution mini-endoscopy pictures
showed thickening of the intestinal wall, edema, and tissue
ﬁbrosis (Figure 1B), whereas immune cell inﬁltration in the
mucosa and crypt elongation became evident in colon his-
tology from Pggt1bDCD4 mice (Figure 1C). Label-free multi-
photon microscopy conﬁrmed the massive colonic
inﬁltration of immune cells and severe tissue architecture
distortion (Figure 1D). Despite high-grade inﬂammation in
the colon, we could not observe any alterations in the small
intestine of Pggt1bDCD4 mice (Supplementary Figure 1D).
The colitis in Pggt1bDCD4 mice went along with increased
gene expression of inﬂammatory mediators (interferon-g,
IL1b, IL17A, S-100A8, and tumor necrosis factor [TNF])
(Figure 1E; Supplementary Figure 1E).
To characterize the inﬁltrating immune cells in the
lamina propria of colitic Pggt1bDCD4 mice, speciﬁc cell
populations were quantiﬁed. We noted a signiﬁcant
accumulation of CD3þ T cells in the colon of Pggt1bDCD4
mice as compared with wild-type controls (Figure 1F);
however, no signiﬁcant changes in the number of B cells,
granulocytes, and dendritic cells were noted (Figure 1F;
Supplementary Figure 1F). Immunostaining analysis
demonstrated increased numbers of colon-inﬁltrating
CD4þ rather than CD8þ T cells in Pggt1bDCD4 mice
(Figure 1G; Supplementary Figure 1G). Taking advantage
of reporter Pggt1bDCD4-tdTomato mice, we could demon-
strate that colitis in Pggt1bDCD4 mice is associated with an
accumulation of tdTomato-expressing PGGT1B-deﬁcient T
cells in the intestinal lamina propria (Supplementary
Figure 1H). Finally, monitoring of Pggt1bDCD4 mice indi-
cated that the colonic inﬂammation increased over time
(Supplementary Figure 1I–K) and pointed to the=
Figure 1. Spontaneous colitis in Pggt1bDCD4 mice. Colonic phe
(B) Endoscopy (n 5). (C) Hematoxylin-eosin (H&E) staining (n 5).
(E) Geneexpression incolon tissue (n 7).NonparametricMann-W
cells) (n  4). (G) CD4, CD8, F4/80, and myeloperoxidase (MPO) imspontaneous development of an age-dependent chronic
colitis mediated by gut-inﬁltrating PGGT1B-deﬁcient
CD4þ T cells.Altered Lymphocyte Localization in Young
Pggt1bDCD4 Mice
To identify cellular and molecular events, which might
mechanistically underlie the spontaneous development of
colitis in Pggt1bDCD4 mice, we analyzed organ histology and
immune cell distribution in young animals (10 weeks of
age). Although endoscopic and histology images did not yet
show any inﬂammatory alterations of colon, ileum, kidney,
liver, and lung (Supplementary Figure 2A and B), some al-
terations could already be identiﬁed in thymus and spleen
of young Pggt1bDCD4 mice (Supplementary Figure 2C).
Enlarged cortex areas in the thymus along with disorga-
nized and smaller T-cell regions in the spleen of Pggt1bDCD4
mice were associated with signiﬁcantly decreased numbers
of CD4þ and CD8þ T cells in the peripheral blood and the
spleen, and a slight accumulation of mature CD4þ in the
thymic medulla (Figure 2A and B; Supplementary
Figure 2D). We excluded impaired thymic T-cell develop-
ment in the absence of PGGT1B, because we detected
normal numbers of CD4-CD8 double-positive and double-
negative cells, with even a tendency toward an increased
percentage of fully developed CD4–single-positive (SP) T
cells (P value ¼ .136) (Supplementary Figure 2E). Moreover,
increased expression of CD62L on thymocytes from
Pggt1bDCD4 mice indicated that PGGT1B-deﬁcient T cells are
able to acquire a mature phenotype (Supplementary
Figure 2F). In contrast to recent publications describing a
massive induction of cell death in thymocytes upon indirect
inhibition of prenylation,7 we could only identify a small
increase in AnnexinþPI early apoptotic cells in thymus
from Pggt1bDCD4 mice compared with control mice
(Supplementary Figure 2G). Thus, our data implicate that
Pggt1bDCD4 mice are not characterized by a major defect in
lymphocyte maturation, but altered trafﬁcking properties of
thymus-egressed T cells.
To validate this hypothesis and verify its causative
involvement in the intestinal pathology of Pggt1bDCD4 mice,
we next analyzed the capacity of PGGT1B-deﬁcient T cells to
inﬁltrate into the gut and gut-associated lymphoid tissue.
Despite signiﬁcantly decreased T-cell populations in
mesenteric lymph nodes, Peyer patches, and in small in-
testine (Figure 2C and D and Supplementary Figure 2H), the
percentage of T cells in the colonic lamina propria and
intraepithelial compartment were normal in Pggt1bDCD4
mice (Figure 2E and F). In accordance with our analyses in
elder mice (Figure 1F and G), an age-dependent colonic
accumulation of PGGT1B-deﬁcient CD4þ T cells, but not
CD8þ T cells could be observed (Figure 2G and H;notype in Pggt1bDCD4 mice (15 weeks). (A) Rectal prolapse.
(D) Label-freemultiphotonmicroscopy;H&Estaining (samearea).
hitneyU test. (F) Immunecell inﬁltration inLPMCs (gatedonviable
munostaining (n  9). AU, arbitrary units.
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regulation of prenylation determines colon localization of T-
helper cells. On the other hand, decreased frequencies of T
cells in the periphery in Pggt1bDCD4 mice were associated
with increased cell death in spleen but not in colon tissue
(Annexin V/PI assay) (Supplementary Figure 2J) and TUNEL
staining (Supplementary Figure 2K). We can assume that
the increased percentages of apoptotic CD4-SP and CD8-SP
thymocytes (Supplementary Figure 2G) and the cell death
induction in the spleen (Supplementary Figure 2J and K)
was not functionally relevant for T-cell gut trafﬁcking.BA
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Primed for Selective Localization to the Intestine
Our data so far suggested that thymus-egressing
PGGT1B-deﬁcient lymphocytes are already primed for se-
lective localization to the colon. Indeed, PGGT1B-deﬁcient
CD4-SP thymocytes showed signiﬁcantly increased expres-
sion levels of the gut homing marker a4b7 integrin, but not
aEb7 or CCR9 (Figure 3A; Supplementary Figure 3A and B).
As the a4b1 integrin has been found to control localization
of CD4þ T cells to the small intestine,20 we also compared
the presence of a4b7 and a4b1 integrins and found a
signiﬁcantly elevated a4b7/a4b1 ratio in CD4þ T cells from
Pggt1bDCD4 mice (Figure 3A). We next analyzed KLF2-
mediated expression of S1P1R as the main pathway regu-
lating maturation and exit of thymocytes. The expression of
S1P1 on cells from thymus or blood did not differ between
control and Pggt1bDCD4 mice (Supplementary Figure 3C),
and Klf2 gene expression was even increased in thymus
from Pggt1bDCD4 mice (Supplementary Figure 3D). Inter-
estingly, the expression of SP1/KLF transcription factors has
been linked to the regulation of integrin expression.21
Moreover, a previous study could show that inhibition of
PGGT1B-mediated prenylation led to RHOA-dependent
activation of the transcription factor SP1.22 Hypothetically,
KLF2/SP1-mediated transcription activation could then
explain the molecular mechanism behind increased
expression of b7 integrin in PGGT1B-deﬁcient T cells.
Indeed we could demonstrate that upregulated KLF2
expression in the thymus of Pggt1bDCD4 mice was associated
with an increased expression and phosphorylation of SP1
(Supplementary Figure 3D).
These data supported the idea that mature thymus-
egressing PGGT1B-deﬁcient T cells express a4b7 integrin
and are thus predisposed for selective localization to the
colon. Thus, we adoptively transferred ﬂuorescence-labeled
thymocytes into Rag1–/– mice and monitored their colon
localization capacity by intravital microscopy. An increased
number of T cells could be retrieved in the distal colon
mucosa of recipient animals receiving thymocytes from=
Figure 2. T-cell compartment inPggt1bDCD4mice. (A–F) CD4þ and
 10). (C) Mesenteric lymphoid nodes (MLN) (n  11). (D) Peyer pa
lymphocytes IEL (n  8). (G, H) Analysis of 10- and 20-week-old
(right) (gated on viable cells) (n 9). (H) Absolute numbers of CD4þ
of age, except G and H.Pggt1bDCD4 mice compared with those adoptively trans-
ferred with wild-type thymocytes, but not in the proximal
colon (Figure 3B; Supplementary Figure 3E). Taking
advantage of Pggt1bDCD4-tdTomato reporter mice, we were
able to track transferred PGGT1B-deﬁcient carboxy-
ﬂuorescein succinimidyl ester-positiveþ-tdTomatoþ thymo-
cytes in recipient mice (Supplementary Figure 3F). Higher
numbers of PGGT1B-deﬁcient than GGTase-I-proﬁcient
donor cells could be detected in colon and blood, but not
in spleen of recipient animals (Figure 3C). These data also
could be conﬁrmed when thymocytes from Pggt1bDCD4-
tdTomato and control mice were transferred competitively
into the same recipient mouse (Figure 3D). Finally, to mimic
the physiological continuous T-cell inﬂux from the thymus,
we performed a repetitive thymocyte transfer. We could
demonstrate accumulation of PGGT1B-deﬁcient T cells in
blood and colon, but not in spleen (Figure 3E;
Supplementary Figure 3G). In summary, the in vivo
observed organ distribution of transferred PGGT1B-deﬁ-
cient thymocytes was in line with the assumption that
downregulation of prenylation promotes the capacity of
thymus-egressed T cells to localize to the colon. To validate
the functional relevance of altered T-cell localization for the
intestinal inﬂammation in Pggt1bDCD4 mice, we performed
an antibody-mediated in vivo blockade of a4b7 in Rag1–/–
mice adoptively transferred with LPMC derived from
Pggt1bDCD4 mice. Indeed, the pro-colitogenic capacity from
LPMC containing PGGT1B-deﬁcient T cells could efﬁciently
be dampened by administration of the a4b7 blocking anti-
body LPAM-1 (Figure 3F). These data convincingly
conﬁrmed the increased a4b7 expression of PGGT1B-
deﬁcient T cells as a key driver of colitis development in
Pggt1bDCD4 mice.Inﬂammatory Gut-Inﬁltrating PGGT1B-deﬁcient T
Cells Produce Th17 Cytokines and Express
RORC
Despite the observed causative link between the colonic
accumulation of PGGT1B-deﬁcient CD4þ T lymphocytes and
the spontaneous colitis in Pggt1bDCD4 mice, it was still un-
clear whether the inﬂammatory effector function of colon-
inﬁltrating lymphocytes might also depend on prenylation.
To focus on primary inﬂammation-independent effects, the
following analyses were mainly performed in Pggt1bDCD4
mice not yet suffering from colitis. Despite a comparable
activation status of PGGT1B-proﬁcient and -deﬁcient lamina
propria CD4þ T cells in the colon (CD69/CD62L expression)
(Supplementary Figure 4A), colon-inﬁltrating CD4þ T cells
in Pggt1bDCD4 mice were characterized by a signiﬁcantly
increased expression of CD38, which has been described as
a potential marker for recently activated T cells23CD8þ cells (gatedon viable cells). (A) Blood (n 14). (B) Spleen (n
tches (n  8). (E) Colon LPMC (n  14). (F) Colon-intraepithelial
mice. (G) Percentage of CD4þ in spleen (left) and colon LPMC
in spleen (left) and LPMC (right).Pggt1bDCD4mice up to 10weeks
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CD4þ T cells in the colonic lamina propria produced
increased amounts of the inﬂammatory cytokine IL17A,
being even more pronounced in elder Pggt1bDCD4 mice (
15 weeks of age) (Figure 4A), implicating that the colitis
further potentiates this phenomenon. Besides IL17A, we
were not able to describe a signiﬁcant PGGT1B-dependent
regulation for any of other analyzed cytokines (interferon-
g, IL-4, IL-9, IL-10, TNF) (Supplementary Figure 4C and D).
According to the observed cytokine proﬁle, we detected an
increased frequency of RORC expressing CD4þ cells in the
lamina propria of Pggt1bDCD4 mice (Figure 4B;
Supplementary Figure 4E) and several Th17-related cyto-
kines (granulocyte-macrophage colony-stimulating factor,
IL17A, IL17F, IL22, and TNF) turned out to be upregulated
in the inﬂamed colon tissue of mice carrying PGGT1B-
deﬁcient T cells (Figure 4C). Interestingly, in vivo treat-
ment of Pggt1bDCD4 mice with the RORC inverse agonist
GSK-80524 was able to signiﬁcantly ameliorate intestinal
inﬂammation (Figure 4D), while antibody-mediated
blockade of IL17A/IL17F alone was unable to dampen co-
litis development (Supplementary Figure 4F). These data
thus identiﬁed Th17 lineage differentiation of colonic T cells
as another key mechanism underlying the colitis develop-
ment in Pggt1bDCD4 mice. In contrast to colon, thymocytes of
Pggt1bDCD4 mice did not show an augmented production of
IL17A (Supplementary Figure 4G), suggesting that the in-
testinal milieu and the local activation of T cells within the
colonic lamina propria play a crucial role in the polarization
of PGGT1B-deﬁcient T cells toward inﬂammatory effector
cells. Overall, we assumed that the spontaneous develop-
ment of colitis in Pggt1bDCD4 mice is driven by a massive
colonic accumulation of IL17A-producing CD4þ T cells.TRHOA as a Key Downstream Target of PGGT1B
in T-Cell Biology
We aimed at the identiﬁcation of key target proteins of
prenylation for T-cell localization. Previously suggested to
control integrin expression,25 Rho proteins appeared as
attractive candidates. We took advantage of Cdc42DCD4,
Rac1DCD4, and RhoADCD4 mice (Supplementary Figure 5A) to
compare the phenotype in the absence of deﬁned Rho
proteins with the described results in Pggt1bDCD4 mice.
Interestingly, Cdc42DCD4 and RhoADCD4 mice exhibited
decreased numbers of CD4þ and CD8þ T cells in blood,
spleen, and mesenteric lymphoid nodes, whereas Rac1DCD4
mice showed normal T-cell inﬁltration (Supplementary
Figure 5B). Moreover, comparable levels of inﬁltrating
CD4þ T cells could be observed in the colon lamina propria=
Figure 3. Localization of PGGT1B-deﬁcient T cells. (A) Gut h
CD4þCD8). Representative dotplots (left);a4b7,a4b1, andaEb7
ratios (right) (n 13). (B–E) Adoptive thymocyte transfer into Rag1–
(carboxyﬂuorescein succinimidyl ester-positive cells/ﬁeld; 20 m
Fluorescence-activated cell sorting of blood, spleen and colon LP
transfer (n 5). (D) Competitive cell transfer (n  9). (E) Repetitive c
absolute numbers (right) (n¼ 3, control; and n¼ 2,Pggt1bDCD4mice
model. Endoscopy and histology (n ¼ 2, control; n ¼ 4,
carboxyﬂuoresceinsuccinimidylester.of Cdc42DCD4 mice, RhoADCD mice, and control littermates,
which mimicked the phenotype observed in Pggt1bDCD4
mice (Supplementary Figure 5C); but only in the case of
RhoADCD mice, increased absolute numbers of CD4þ could
be observed in the colon (Figure 5A). Interestingly, the
increased numbers of CD4-SP and CD8-SP and decreased
frequency of double-positive cells in the thymus of RhoADCD
mice (Supplementary Figure 5E), overlapped with a milder
but similar effect in Pggt1bDCD4 mice (Supplementary
Figure 2E). RHOA-deﬁcient CD4þ thymocytes, by analogy
with PGGT1B-deﬁcient thymocytes, showed a marked in-
crease in the a4b7/a4b1 expression ratio (Figure 5B;
Supplementary Figure 5F), which might underlie their colon
localization. In accordance with these ﬁndings, adoptively
transferred RHOA-deﬁcient thymocytes showed an
improved ability to home into the colon of Rag1–/– recipient
animals (Figure 5C), which was not the case for CDC42-
deﬁcient thymocyte (Supplementary Figure 5G). Finally,
only in RhoADCD4 mice were we able to detect spontaneous
development of colitis, as demonstrated by increased
endoscopy and histology scores (Supplementary Figure 5H).
Of note, the spontaneous development of colon inﬂamma-
tion in RhoADCD mice could be signiﬁcantly inhibited on
treatment with the a4b7 neutralizing LPAM-1 antibody
(Figure 5D; Supplementary Figure 5I). Similarly to
Pggt1bDCD4 mice, lamina propria CD3þCD4þ cells from
RhoADCD4 mice showed increased expression of IL17A
(Figure 5E; Supplementary Figure 5J), and colon tissue of
RhoADCD mice was characterized by augmented levels of
Th17-related cytokines (Supplementary Figure 5K). In
summary, these observations underlined the functional
relevance of a4b7-mediated T-cell localization to the gut for
the intestinal phenotype of RhoADCD mice and strongly
implicated the involvement of colonic Th17-polarized
effector T cells.
Overall, the fact that RhoADCD and Pggt1bDCD4 mice dis-
played striking parallels with regard to integrin marker
expression on thymocytes, T-cell localization, expression of
inﬂammatory cytokines, and intestinal phenotype strongly
suggested RHOA as a key downstream target protein of
PGGT1B in T-cell biology. Indeed, the absence of PGGT1B in
CD4-SP thymocytes was associated with a decreased acti-
vation status of RHOA protein, demonstrated by the
decreased ratio between activated and total RHOA in CD4-
SP cells from Pggt1bDCD4 mice (Supplementary Figure 5L
andM). Moreover, we could demonstrate a marked decrease
of membrane-bound RHOA, but not CDC42, in thymocytes
from Pggt1bDCD4 mice (Supplementary Figure 5N), leading
to decreased activation of RHOA-downstream pathway, as
indicated by impaired phosphorylation of MLC2oming marker expression in CD4-SP thymocytes (gated on
expression (middle); anda4b7/a4b1,aEb7/a4b1, anda4b7/aEb1
/– mice. (B) Postmortem confocal microscopy of the distal colon
agniﬁcation; 2 stacks/mouse; 2 pictures/stack) (n ¼ 5). (C–E)
MC (gated on singlets; lymphoid cells). (C) Noncompetitive cell
ell transfer; dot plots (left), and quantiﬁcation in percentage and
). (F) Anti-a4b7 antibody treatment in the adoptive LPMC transfer
Pggt1bDCD4; and n ¼ 3, Pggt1bDCD4þ anti-a4b7). CFSE,
Figure 4. Effector function of PGGT1B-deﬁcient T cells. (A) IL17A expression fromCD4þ LPMC; dot plots, and quantiﬁcation (gated
on singlets-lymphoid cells, CD4þ); mice 10 (left); and15weeks of age (right) (n 7;). (B) Analysis of transcription factors in LPMC
(n¼4);mice10weeksofage. (C)GeneexpressionofTh17-relatedcytokines incolon tissue (n4);mice10 (left), and15weeksof
age (right). (D) Treatment of Pggt1bDCD4 mice with GSK805 (n ¼ 2, control; n¼ 3, Pggt1bDCD4; and n ¼ 4, Pggt1bDCD4 þ GSK805).
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Figure 5. Role of PGGT1B-mediated prenylation targets for T-cell localization. (A, B) Cdc42DCD4, Rac1DCD4, and RhoADCD4 mice.
(A) CD4 immunostaining in colon tissue from20-week-oldmice (n 6). (B)a4b7/a4b1,aEb7/a4b1, anda4b7/aEb1 ratios inmice10
weeks of age (n 7). (C) Noncompetitive cell transfer of RHOA-deﬁcient thymocytes into Rag1–/– mice. Fluorescence-activated cell
sorting analysis of colon LPMC, spleen, and blood (gated on singlets; lymphoid cells) (n 5). (D) Treatment of RhoADCD4 mice with
anti-a4b7 antibody (n¼ 5, control; n¼ 5,RhoADCD4; andn¼ 4,RhoADCD4þ anti-a4b7). (E) IL17Aexpression fromCD3þCD4þ colon
LPMC (gated on CD3þCD4þ). Mice 10 (left); and 15 weeks of age (right) (n 6).
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the absence of PGGT1B-mediated prenylation in T cells re-
sults in an impaired function of RHOA, which in turn might
drive the development of spontaneous colitis.
T Cells in the Inﬂamed Intestinal Mucosa of
Patients With IBD Show a Decreased Expression
of PGGT1B
Our ﬁndings in Pggt1bDCD4 mice demonstrated that
PGGT1B-mediated prenylation crucially impacts on colonic
immune homeostasis. We then assumed that chronic intes-
tinal inﬂammation in patients with IBD might also be
inﬂuenced by potential alterations within the prenylation
machinery of T cells. Using an indirect ﬂow cytometric
staining, no signiﬁcant differences in the signal intensity or
percentage of PGGT1Bþ T cells could be observed in pe-
ripheral blood mononuclear cells isolated from patients
with IBD and healthy donors (Supplementary Figure 6A and
B). However, similar analyses revealed that lamina propria
CD3þ or CD3þCD4þ T cells derived from patients with
clinically manifest IBD are characterized by decreased per-
centages of PGGT1Bþ cells compared with patients in
remission (Figure 6A and B ). Accordingly, Pggt1b gene
expression was decreased in LPMCs isolated from inﬂamed
gut areas of patients with IBD compared with unaffected
control tissue (Supplementary Figure 6C). Interestingly, the
decreased PGGT1B expression was restricted to patients
with mild to moderate inﬂammation (Figure 6C). We hy-
pothesized that exacerbated intestinal inﬂammation might
trigger secondary prenylation-independent lymphocyte
recruitment. Despite only minor differences between UC
and CD patients (Figure 6D), the decrease in PGGT1Bþ cells
became more obvious in colonic than small intestine sam-
ples from patients with IBD (Figure 6E). This is in line with
the fact that PGGT1B-deﬁcient T cells in Pggt1bDCD4 mice
showed a selective colon tropism and might therefore be of
particular relevance in patients with IBD with a colon-
restricted disease manifestation. Together, we could
demonstrate that T cells inﬁltrating the inﬂamed gut of
patients with IBD show a decreased expression of PGGT1B,
suggesting that the newly discovered functional link be-
tween PGGT1B-mediated prenylation and intestinal ho-
meostasis in mice is relevant for IBD pathogenesis.
PGGT1B-mediated Prenylation Regulates Gut
Homing Marker Expression and Effector Function
of Human T Cells
Next, we analyzed the cellular consequence of experi-
mentally modiﬁed prenylation levels in primary human T
cells. We took advantage of the speciﬁc GGT inhibitor GGTI-
298, which inhibited prenylation in human peripheral blood
CD4þ T cells (Supplementary Figure 7A). GGTI-298 treat-
ment was not associated with induction of cell death in
human T cells (Supplementary Figure 7B) or altered acti-
vation status (Supplementary Figure 7C). In agreement with
our ﬁndings in Pggt1bDCD4 mice (Figure 3A), we could
indeed detect an increased expression of a4b7 integrin afterexposure of stimulated human CD4þ T cells to GGTI-298
compared with untreated cells (Figure 7A). The GGTI-298-
induced increase of a4b7 expression occurred as a speciﬁc
consequence of GGTase inhibition and could not be
observed in PGGT1B-deﬁcient thymocytes (Supplementary
Figure 7D). In donors characterized by a GGTI-298–
induced a4b7 upregulation, a similar a4b7-inducing effect
in T cells could be described for simvastatin, which limits
the cellular availability of isoprenoids and thereby repre-
sents an indirect prenylation inhibitor (Figure 7B).
Increased expression of a4b7 integrin on treatment with
GGTI-298 also occurred in LPMC isolated from patients with
IBD in remission (Supplementary Figure 7E). Furthermore,
the GGTI-298–mediated effect on a4b7 expression could be
reverted by previous RHO, but not RAC/CDC42, activation
(Figure 7C, Supplementary Figure 7F). These ﬁndings indi-
cated that prenylation and RHOA function markedly affect
a4b7 expression in human T cells, suggesting that RHOA
activation in T cells might be a new approach to regulate
colonic T-cell localization in IBD.Discussion
Our study identiﬁed for the ﬁrst time a link between
prenylation in T cells and chronic intestinal inﬂammation in
patients with IBD. The abrogation of geranylgeranylation
within T cells in mice leads to an age-dependent sponta-
neous intestinal inﬂammation mimicking colonic inﬂam-
mation in IBD. Mechanistically, our data suggest that
thymus-egressing PGGT1B-deﬁcient T cells are primed for
a selective colon tropism, based on a SP1-dependent in-
duction of a4b7 integrin expression. Thus, PGGT1B-
deﬁcient a4b7-expressing lymphocytes potentially bypass
antigen encountering in secondary lymphoid organs and
directly localize to the intestine where they might get acti-
vated by local antigen-presenting cells,26 such as dendritic
cells, macrophages, or gd T cells. The local activation of
PGGT1B-deﬁcient T cells in the intestine was further sup-
ported by their increased expression of CD38.23 Subse-
quently, PGGT1B-deﬁcient T cells accumulate within the
colon mucosa, where they undergo polarization towards a
Th17-like inﬂammatory phenotype promoting the initiation
of colitis. Most likely, local antigen presentation in the
presence of cytokines, like IL-1b or TNF, and microbial
products, contributes to the Th17 polarization of inﬁltrating
PGGT1B-deﬁcient T cells. In accordance with published data
in other experimental models of colitis,24 our analyses in
Pggt1bDCD4 mice revealed that inhibition of RORC sup-
pressed gut inﬂammation underlining a key role of Th17
cells for colitis development. However, neutralization of IL-
17A/F failed to signiﬁcantly ameliorate colitis in Pggt1bDCD4
mice, suggesting that blockade of the Th17 lineage via RORC
rather than the neutralization of single Th17 cytokines is
required for suppression of colitis in Pggt1bDCD4 mice.
Previous studies on inactivation of IL-17A and IL-17F in
various colitis models have led to partial contradictory
results with beneﬁcial, neutral, or even detrimental
effects.27–33 Thus, the outcome of IL17-targeting strategies
Figure 6. PGGT1B-mediated prenylationwithin T cells in human IBD. Expressionof PGGT1BonLPMC (CD3þ; CD3þCD4þ) isolated
frompatients with IBD. (A) Dot plots. (B) Mean intensity signal (left);%of PGGT1Bþ (middle); and%of PGGT1B cells (right) (n¼ 25;
n ¼ 8, Control; n ¼ 17, Inﬂamed). (C–E) Distribution analysis considering (C) severity of inﬂammation; (D) CD/UC diagnosis (n ¼ 8,
normal; n ¼ 12, CD; n ¼ 5, UC); and (E) disease localization (n ¼ 8, normal; n ¼ 12, colon; n ¼ 4, ileum).
November 2019 Inhibiting PGGT1B Leads to Colitis in Mice 1305
BA
SI
C
AN
D
TR
AN
SL
AT
IO
NA
L
AT
1306 López-Posadas et al Gastroenterology Vol. 157, No. 5
BASIC
AND
TRANSLATIONAL
AT
November 2019 Inhibiting PGGT1B Leads to Colitis in Mice 1307
BA
SI
C
AN
D
TR
AN
SL
AT
IO
NA
L
ATmay depend on various parameters, such as the selected
colitis model and the treatment schedule.
The introduction of biological agents signiﬁcantly
improved the prognosis of patients with IBD; however,
there still exist 30% to 50% of anti-TNF nonresponders,34
indicating the urgent need for optimized treatment regi-
mens. In that framework, strengthening of epithelial barrier
function35 and control of T-cell response4 represent prom-
ising concepts. Strikingly, gut-inﬁltrating T cells in patients
with IBD with active colon disease manifestation showed a
decreased expression of PGGT1B, which might underlie
their augmented a4b7 integrin expression36 and inﬂam-
matory cytokine proﬁle.37 Our data implicate that PGGT1B-
deﬁcient T cells potentially bypass antigen presentation in
secondary lymphoid organs and might be strictly dependent
on local activation in the gut. We then hypothesize that the
high level of antigen load in the distal colon38 might
particularly promote colon tropism and local accumulation
of a4b7-expressing PGGT1B-deﬁcient T cells. Together, pa-
tients with IBD with a relevant involvement of the colon
might in particular beneﬁt from a therapeutic restoration of
deﬁcient prenylation in the gut. A potential combination
with regulators of prenylation might further improve the
clinical performance of recently introduced anti-adhesion
drugs.39 This hypothesis is further supported by the
observation that antibody-mediated blockade of a4b7
integrins was able to signiﬁcantly ameliorate the sponta-
neous intestinal pathology in RhoADCD4 mice and the
induced colitis in Rag1–/– mice adoptively transferred with
PGGT1B-deﬁcient LPMCs (Figure 5D and 3F). Based on the
recently described PGGT1B-mediated maintenance of
epithelial integrity in the gut,5 pharmacological modulation
of prenylation might even result in a double beneﬁcial effect,
acting both on T cells and epithelium.
Among downstream targets of PGGT1B, Rho proteins
play a key role for T-cell biology.8–10 Of note, it has been
suggested that RHOA is activated in gut tissue samples from
patients with IBD.40 However, because RHOA is ubiquitously
expressed within the intestinal mucosa, it remained open in
how far the activation status of RHOA within the T-cell
compartment contributed to this phenomenon. In our cur-
rent study, we were now able to demonstrate that the
absence of PGGT1B-mediated prenylation in T cells results
in an impaired RHOA activation and function. Accordingly,
RHO activation was associated with ameliorated epithelial
alterations in Pggt1biDIEC mice,5 and signiﬁcantly dampened
a4b7 expression of human GGTI-treated CD4þ T cells
(Figure 7C). These data were in accordance with the concept
that GGTase-mediated prenylation and not GTP-loading
determines T-cell function and Rho-mediated effects on T-
cell migration.41 Overall, modulation of RHO inhibitors/ac-
tivators or interference with RHO downstream targets
appear as promising strategies for IBD therapy, for instance,=
Figure 7.Geranylgeranylation-dependent expression of integrin
cells. (A) Treatment with GGTI-298 with or without IL7 stimulation
mM); selected patients showing increased a4b7 expression upon
CDC42 activators before GGTI-298 (3 mM) stimulation (n ¼ 8).blocking intrinsic and GAP stimulated GTPase activity
resulting in constitutively active GTPases.42 The fact that
RhoADCD4 mice developed a milder intestinal phenotype
than Pggt1bDCD4 mice might be because of a potential
functional compensation of the RHOA deﬁciency by other
Rho GTPases.13
Mechanistic studies suggested that prenylation is not
affecting b7 function directly, but its expression via the
RHOA/KLF2/SP1-dependent pathway. Our data strongly
implicate that increased a4b7/a4b1 expression ratio of
RHOA-deﬁcient thymocytes (Figure 5B) underlies their
preferential localization to the intestine (Figure 5A;
Supplementary Figure 5B and C) and the subsequent in-
testinal inﬂammation in RhoADCD4 mice (Figure 5D and E;
Supplementary Figure 5H–K). Janagathan et al.43 postu-
lated that RHOA activation favors retention of human
hematopoietic stem/progenitor cells in their niche, which
is in line with decreased numbers of T cells in blood or
spleen in RhoADCD4 mice (Supplementary Figure 5B). In
contrast to the spontaneous gut inﬂammation in RhoADCD4
mice, inhibition of RHOA within T cells has recently been
discussed as a therapy strategy for multiple sclerosis, due
to reduced T-cell migration.10 This controversy might be
explained by the use of different Cre-deleter strains (Lck-
Cre versus CD4Cre), and the occurrence of Rhoa deletion
at different stages of thymic T-cell maturation. Because
we postulate that the preference of PGGT1B-deﬁcient T
cells for localization to colon is predetermined within the
thymus, the observed differences in thymocyte matura-
tion between both strains might also affect the integrin
expression of thymus-egressing lymphocytes. Neither the
localization to the intestine nor the behavior of gut T cells
in Rhoa-LckCre mice was investigated.
Based on the here presented data, PGGT1B-mediated
prenylation was identiﬁed as a new regulator of T-cell
localization and effector function. The functional rele-
vance of this ﬁnding for gut homeostasis and IBD patho-
genesis was highlighted by the observation that
Pggt1bDCD4 mice spontaneously developed a chronic co-
litis and LPMC of patients with IBD could be characterized
by decreased PGGT1B expression. Among GGTase-I
downstream targets, RHOA was able to link defects in
PGGT1B-mediated prenylation with an augmented locali-
zation to colon and inﬂammatory effector function of T
lymphocytes. Together, our data support the emerging
theory of a prenylation-based therapy in IBD.Study Approval
Animal protocols were approved by the Institutional
Animal Care and Use Committee of the University of
Erlangen and the Regierung Mittelfranken (Würzburg, Ger-
many). Collection of human samples was approved by Ethicss on human T cells. a4b7 expression on human CD3þCD4þ
(n ¼ 6). (B) Treatment with GGTI-298 (3 mM) or Simvastatin (5
GGTI-298 treatment (n ¼ 7). (C) Treatment with RHO or RAC/
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